Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
about
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axisThe cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signalingGrowth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease.Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferationNeoadjuvant Endocrine Therapy in Breast CancerLow levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.δEF1 down-regulates ER-α expression and confers tamoxifen resistance in breast cancerWnt signaling in estrogen-induced lactotroph proliferation.Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancerMethylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone.Differential effects of estrogen and estrogen receptor antagonist, ICI 182 780, on the expression of calbindin-D9k in rat pituitary prolactinoma GH₃ cells.Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy.An ethanolic extract of black cohosh causes hematological changes but not estrogenic effects in female rodents.Estrogen receptor prevents p53-dependent apoptosis in breast cancer.Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal womenCurcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.MicroRNA and cancer chemoprevention.Molecular markers and targets for colorectal cancer prevention.Estrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs.N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial.Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.GPR30 differentially regulates short latency responses of luteinising hormone and prolactin secretion to oestradiolMicroRNAs as therapeutic targets in chemoresistance.Effects of resveratrol on cell growth and prolactin synthesis in GH3 cells.Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokineticsRevisiting ligand-induced conformational changes in proteins: essence, advancements, implications and future challenges.Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action.Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling.17β-oestradiol acts as a negative modulator of insulin-induced lactotroph cell proliferation through oestrogen receptor α, via nitric oxide/guanylyl cyclase/cGMP.[Dopamine-agonist resistant prolactinomas: diagnosis and management].In silico prediction of chemical mechanism of action via an improved network-based inference method.Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas.Oestradiol stimulates prolactin secretion in women through oestrogen receptors.Kisspeptin regulates tuberoinfundibular dopaminergic neurones and prolactin secretion in an oestradiol-dependent manner in male and female rats.Evaluation of the effects of fulvestrant and micronized progesterone on the post-operative adhesion formation and ovarian reserve in rat model with immunohistochemical and biochemical analysis.Estrogen promotes megakaryocyte polyploidization via estrogen receptor beta-mediated transcription of GATA1.Peripheral estrogen receptor-alpha selectively modulates the waveform of GH secretory bursts in healthy women.
P2860
Q28087609-D16DA842-C020-4988-AD13-083C16920897Q28252084-B4CC0262-0407-43FA-A773-04A407B4EFEDQ33559806-FDB78A48-A62F-4581-9CCC-23EAC6765876Q33564204-42F90E3B-EB2B-4640-B7D6-62EE418B2579Q34096272-D53D1939-FA09-4A71-8878-BEA6422D19B4Q34468550-EACFAE59-E8A5-4D97-B832-CD6AD62DDED2Q34533761-3F9DAC12-4489-48EE-BB83-C7F33A4EB77CQ34541487-680B84B7-94BC-472A-99D9-1051676E5325Q34619220-B6FD1125-B469-46AD-A787-9A292D8FA23EQ34751984-8A891668-1531-4100-B432-C4D386E41AB5Q35038463-ED26C34C-4B31-4DDA-B1BE-FC1CB788B117Q35113327-602EDBC5-4434-4179-9EA4-7E99AD365F91Q35159751-C29756C3-4DFB-4A92-BE1A-9D996642D658Q36173709-B48E19EE-F3FE-43F0-8827-103C90814979Q36397942-F05ABB05-BF89-468A-8A8E-9053E1A79A36Q36494366-3C98F10A-5C2F-4B70-B4A6-C538B2996D23Q36796675-55D05F74-51F6-4FB0-BF03-F75FCD30936FQ36816367-F22F4BD9-7CA0-446B-BF4E-F7CFA796767DQ37045028-2B8BA818-D94A-46E2-831C-9D991775A5BAQ37106608-8CBBAB33-F581-47F5-8D11-E563387E525BQ37200495-2412DBB1-DF09-47E5-847A-E59546A01AA1Q37298081-F4086972-C0D1-4CBE-82F6-4DE9F251F3A3Q37373591-EE9A0A9B-B809-47C1-9000-A6AFAC86DBF2Q37381107-327174DB-0046-4D2C-A422-8D299112C0E2Q37662033-DBC758B2-A20D-4B27-B9A5-04EB67C1345BQ37707038-F1A4DFB7-DC67-4C51-B27B-10B006FC7D55Q38034245-0D747C16-9280-45F6-BE68-CD8268FCFB66Q38151947-AD96E5DF-2F71-4907-9598-0FC41DA39216Q39035803-1F8B8FA0-DCEE-4562-A126-8FF70BB14087Q39555908-75E19869-1A77-4444-8CD5-2A627BD25123Q40050884-0D02FF8B-7CB3-4F5E-A2A1-15C9AE5F5D2AQ42871688-E7C412A0-1F1F-4C73-A17A-8B05EF66B85FQ46917426-1A361C64-70E0-4869-8DD8-DB17F4ABAF94Q47168067-46631223-FBE2-40FA-8A52-E499A6DA2DBBQ47168700-60CAAD17-67EC-409E-9650-9A160B3FA84DQ48391388-5A392911-3D19-4A53-B63B-1523B96B6AE4Q48432583-8BF0A928-D4F2-473C-AFB2-03904EAA72C2Q50993758-69B89A4F-2667-478F-BB89-96890781DBFBQ51109149-865A0B0A-A585-4D63-965B-3E04AA8FB226Q51466111-51165BFC-503A-42D8-8BF2-F0EA91F74317
P2860
Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Differential effects of estrog ...... eration and prolactin release.
@ast
Differential effects of estrog ...... eration and prolactin release.
@en
Differential effects of estrog ...... eration and prolactin release.
@nl
type
label
Differential effects of estrog ...... eration and prolactin release.
@ast
Differential effects of estrog ...... eration and prolactin release.
@en
Differential effects of estrog ...... eration and prolactin release.
@nl
prefLabel
Differential effects of estrog ...... eration and prolactin release.
@ast
Differential effects of estrog ...... eration and prolactin release.
@en
Differential effects of estrog ...... eration and prolactin release.
@nl
P2093
P1476
Differential effects of estrog ...... eration and prolactin release.
@en
P2093
Lauren Foster
Leighton Sneade
Sanjay Kansra
Sayaka Yamagata
P356
10.1016/J.MCE.2005.04.008
P577
2005-07-01T00:00:00Z